Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/56777
Title: Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas.
Authors: 
Mesh: 
Issue Date: 25-Sep-2019
Citation: Nat Commun.2019;(10)1:4343
Abstract: Infant gliomas have paradoxical clinical behavior compared to those in children and adults: low-grade tumors have a higher mortality rate, while high-grade tumors have a better outcome. However, we have little understanding of their biology and therefore cannot explain this behavior nor what constitutes optimal clinical management. Here we report a comprehensive genetic analysis of an international cohort of clinically annotated infant gliomas, revealing 3 clinical subgroups. Group 1 tumors arise in the cerebral hemispheres and harbor alterations in the receptor tyrosine kinases ALK, ROS1, NTRK and MET. These are typically single-events and confer an intermediate outcome. Groups 2 and 3 gliomas harbor RAS/MAPK pathway mutations and arise in the hemispheres and midline, respectively. Group 2 tumors have excellent long-term survival, while group 3 tumors progress rapidly and do not respond well to chemoradiation. We conclude that infant gliomas comprise 3 subgroups, justifying the need for specialized therapeutic strategies.
PMID: 31554817
URI: https://hdl.handle.net/20.500.12530/56777
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > FIB H. Infantil U. Niño Jesús > Artículos

Files in This Item:
File SizeFormat 
PMC6761184.pdf2.76 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons